Insulinoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| (4 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Insulinoma}} | {{Insulinoma}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}; {{AE}} {{ADS}} | ||
==Overview== | ==Overview== | ||
There are no | There are no established measures for the secondary prevention of insulinoma. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no | *There are no established measures for the secondary prevention of insulinoma. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | {{WH}} | ||
{{WS}} | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:07, 27 November 2017
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Insulinoma secondary prevention |
|
Risk calculators and risk factors for Insulinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There are no established measures for the secondary prevention of insulinoma.
Secondary Prevention
- There are no established measures for the secondary prevention of insulinoma.